Download Free Sample Report

Lung Cancer Diagnostics Market, Global Outlook and Forecast 2023-2030

Lung Cancer Diagnostics Market, Global Outlook and Forecast 2023-2030

  • Published on : 26 September 2023
  • Pages :68
  • Report Code:SMR-7818328

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Lung Cancer Diagnostics market was valued at US$ 1938 million in 2022 and is projected to reach US$ 2805.4 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostics. This report contains market size and forecasts of Lung Cancer Diagnostics in global, including the following market information:

  • Global Lung Cancer Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
  • Global top five companies in 2022 (%)

As people's awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
We surveyed the Lung Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Lung Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
Global Lung Cancer Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Lung Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Industrial
Healthcare
Other
Global Lung Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Lung Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lung Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
BioM?rieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer Diagnostics, market overview.
Chapter 2: Global Lung Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Lung Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.